[Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients].
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007275:Injections, Intravenous; D008297:Male; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D006834:Hydrazines; D011724:Pyridazines; D014665:Vasodilator Agents
Farmacologia clinica di un nuovo farmaco ipotensivo ad azione vasodilatatrice periferica (I.S.F. 2123); effetti della somministrazione acuta in vena nel paziente iperteso.